| Literature DB >> 30356659 |
Abstract
PURPOSE: The aim of this study was to investigate the influence of the cardiorespiratory fitness level on the response to high-intensity interval training (HIIT) with an individually adjusted running speed of the same relative intensity. The evaluation focused on acute cardiorespiratory response, postexercise cardiac autonomic modulation (heart rate variability (HRV)) and biochemical markers of inflammation, oxidative stress, and muscle damage.Entities:
Keywords: Creatine kinase; Heart rate variability; Inflammation; Myoglobin; Total antioxidant capacity; Training status
Year: 2016 PMID: 30356659 PMCID: PMC6189275 DOI: 10.1016/j.jshs.2016.11.001
Source DB: PubMed Journal: J Sport Health Sci ISSN: 2213-2961 Impact factor: 7.179
Basic study groups characteristics and preintervention graded exercise test results (mean ± SD).
| WT ( | MT ( | U ( | |
|---|---|---|---|
| Age (year) | 24.18 ± 1.80 | 22.60 ± 1.20 | 24.44 ± 2.54 |
| Height (cm) | 180.55 ± 5.66 | 180.50 ± 5.57 | 180.89 ± 6.26 |
| Weight (kg) | 76.26 ± 6.38 | 80.14 ± 8.89 | 80.64 ± 14.41 |
| Body fat (%) | 10.45 ± 3.34 | 13.78 ± 1.94 | 14.31 ± 5.61 |
| EA (h/week) | 12.00 ± 5.89 | 6.05 ± 2.22 | Null |
| VO2max (mL/kg/min) | 61.39 ± 3.63 | 53.46 ± 2.80 | 47.21 ± 3.98 |
| 19.55 ± 1.57 | 17.44 ± 0.86 | 14.66 ± 0.82 | |
| 21.03 ± 1.53 | 19.26 ± 0.69 | 16.28 ± 1.15 | |
| HRmax (bpm) | 192.73 ± 4.63 | 198.90 ± 3.91 | 196.22 ± 9.11 |
| VT2 (bpm) | 178.09 ± 6.32 | 177.20 ± 11.62 | 175.78 ± 12.26 |
| VT2 (%VO2max ) | 85.27 ± 3.35 | 80.90 ± 4.12 | 77.50 ± 7.17 |
| GXT duration (min:s) | 12:58 ± 1:13 | 11:16 ± 0:39 | 8:06 ± 1:05 |
| RPE (points) | 18.00 ± 1.91 | 18.30 ± 0.78 | 18.22 ± 0.79 |
Abbreviations: EA = self-reported intentional exercise activity; GXT = graded exercise test; HRmax = maximal heart rate; MT = moderately trained; RPE = Borg's rating of perceived exertion; U = untrained; vinc.t. = peak incremental test speed; maximal oxygen consumption; minimal running speed required to elicit VO2max; VT2 = second ventilatory threshold; WT = well trained.
Comparison of the GXT results.
| WT | WT | MT | |
|---|---|---|---|
| VO2max | −1.93 (−2.55, −1.30) | −4.09 (−5.12, −3.07) | −2.12 (−3.23, −1.01) |
| −1.26 (−1.84, −0.67) | −3.19 (−3.82, −2.57) | −2.97 (−3.76, −2.18) | |
| −1.11 (−1.66, −0.56) | −3.30 (−4.02, −2.59) | −4.35 (−5.55, −3.15) | |
| HRmax | 1.17 (0.53, 1.82) | 0.66 (−0.54, 1.87) | −0.59 (−1.99, 0.80) |
| VT2 | −1.25 (−2.09, −0.41) | −2.32 (−3.87, −0.76) | −0.79 (−1.97, 0.39) |
| GXT duration | −1.08 (−1.62, −0.53) | −3.99 (−4.85, −3.14) | −5.08 (−6.48, −3.68) |
Note: The between-group differences are expressed as standardized (Cohen) difference of the mean (90%CL) and rating of the difference (% chance of higher/trivial/lower differences).
Abbreviations: CL = confidence limits; GXT = graded exercise test; HRmax = maximal heart rate; MT = moderately trained; U = untrained; vinc.t. = peak incremental test speed; ; ; VT2 = second ventilatory threshold; WT = well trained.
The characteristics of the response to the HIIT intervention (mean ± SD) and the between-group differences (warm-up and cool-down excluded).
| WT | MT | U | WT | WT | MT | |
|---|---|---|---|---|---|---|
| Mean HR (bpm) | 162.9 ± 9.5 | 165.3 ± 12.5 | 166.5 ± 10.8 | 0.21 (−0.64, 1.06) | 0.34 (−0.44, 1.12) | 0.10 (−0.58, 0.77) |
| Mean HR (%HRmax) | 84.5 ± 4.4 | 83.0 ± 5.1 | 84.9 ± 4.1 | −0.32 (−1.10, 0.46) | 0.08 (−0.62, 0.77) | 0.33 (−0.32, 0.98) |
| Mean VO2 (mL/kg/min) | 40.1 ± 3.1 | 36.6 ± 3.2 | 32.6 ± 3.3 | −1.11 (−1.85, −0.38) | −2.51 (−3.43, −1.59) | −1.27 (−2.13, −0.40) |
| Mean VO2 (%VO2 | 65.4 ± 4.1 | 68.7 ± 6.3 | 68.6 ± 3.1 | 0.66 (−0.22, 1.54) | 0.69 (0.04, 1.35) | 0.02 (−0.58, 0.62) |
| Mean VO2 (%VO2 | 76.5 ± 4.2 | 81.1 ± 7.5 | 80.3 ± 3.2 | 0.90 (−0.07, 1.88) | 0.79 (0.15, 1.44) | −0.07 (−0.65, 0.51) |
| Lactateend (mmol/L) | 12.6 ± 3.9 | 11.6 ± 4.3 | 13.2 ± 3.4 | −0.24 (−0.99, 0.51) | 0.13 (−0.55, 0.81) | 0.33 (−0.33, 0.98) |
| Mean RER | 0.97 ± 0.03 | 0.97 ± 0.04 | 0.96 ± 0.04 | −0.04 (−0.82, 0.73) | −0.14 (−0.95, 0.67) | −0.08 (−0.81, 0.66) |
| RPE | 15.6 ± 2.3 | 17.1 ± 1.2 | 16.5 ± 1.9 | 0.62 (0.07, 1.17) | 0.37 (−0.28, 1.01) | −0.53 (−1.59, 0.54) |
Note: The between-group differences are expressed as standardized (Cohen) difference of the mean (90%CL) and rating of the difference.
Abbreviations: CL = confidence limits; HIIT = high-intensity interval exercise; HR = heart rate; Lactateend = lactate concentration immediately after HIIT; MT = moderately trained; RER = respiratory exchange ratio; RPE = rating of perceived exertion; U = untrained; oxygen consumption; WT = well trained.
Fig. 1The HR (A), VO2 (B), and RER (C) dynamics during the HIIT intervention (mean data). The gray shaded areas highlight the high-intensity intervals. HIIT = high-intersity interval training; HR = heart rate; RER = respiratory exchange ratio; oxygen consumption.
Fig. 2(A) The ln rMSSD changes after the HIIT intervention (mean); (B) expressed as standardized difference (90%CI) from the pre-exercise values. The gray shaded area indicates the smallest worthwhile change. CI = confidence interval; HIIT = high-intensity interval training; ln rMSSD = square root of the mean sum of the squared differences between R-R intervals; MT = moderately trained; U = untrained; WT = well trained.
Fig. 3The IL-6 (A), TAC (B), CK (C), and Mb (D) changes after high-HIIT and control trial expressed as standardized difference (90% confidence interval) from the pre-exercise values. The gray shaded areas indicate the smallest worthwhile changes. CK = creatine kinase; HIIT = high-intensity interval training; IL-6 = interleukin-6; Mb = myoglobin; MT = moderately trained; TAC = total antioxidant capacity; U = untrained; WT = well trained.
Biochemical markers characteristics in response to HIIT (mean ± SD).
| Pre-exercise | Post-exercise | 2 h post-exercise | 4 h post-exercise | |
|---|---|---|---|---|
| WT | 0.95 ± 0.23 | 1.62 ± 0.35 | 1.01 ± 0.35 | 1.02 ± 0.27 |
| MT | 0.94 ± 0.29 | 1.83 ± 0.60 | 0.98 ± 0.43 | 1.17 ± 0.30 |
| U | 0.96 ± 0.34 | 1.61 ± 0.45 | 1.06 ± 0.30 | 0.97 ± 0.22 |
| WT | 1.64 ± 0.06 | 1.78 ± 0.09 | 1.73 ± 0.09 | 1.72 ± 0.06 |
| MT | 1.62 ± 0.06 | 1.75 ± 0.09 | 1.71 ± 0.07 | 1.67 ± 0.09 |
| U | 1.61 ± 0.07 | 1.75 ± 0.07 | 1.73 ± 0.06 | 1.70 ± 0.06 |
| WT | 4.17 ± 1.76 | 5.11 ± 1.73 | 4.64 ± 1.71 | 4.74 ± 1.71 |
| MT | 2.71 ± 1.63 | 3.51 ± 1.60 | 3.40 ± 1.52 | 3.73 ± 1.47 |
| U | 2.65 ± 1.99 | 3.44 ± 1.94 | 3.41 ± 1.94 | 3.63 ± 1.94 |
| WT | 30.88 ± 1.36 | 41.72 ± 1.33 | 56.71 ± 1.81 | 45.21 ± 1.82 |
| MT | 26.67 ± 1.24 | 37.84 ± 1.27 | 70.11 ± 1.68 | 54.23 ± 1.73 |
| U | 29.03 ± 1.10 | 37.80 ± 1.16 | 57.87 ± 1.40 | 50.97 ± 1.60 |
Abbreviations: CK = creatine kinase; IL-6 = interleukin-6; Mb = myoglobin; MT = moderately trained; TAC = total antioxidant capacity; U = untrained; WT = well trained.